Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 99
(6)
◽
pp. E1088-E1096
◽
2021 ◽
Vol 7
(1)
◽
2015 ◽
Vol 98
(10)
◽
pp. 6706-6712
◽
Keyword(s):
2015 ◽
Vol 12
(S1)
◽